Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as GBX 1.40 ($0.02) and last traded at GBX 1.50 ($0.02), with a volume of 2272402 shares trading hands. The stock had previously closed at GBX 1.65 ($0.02).
Cizzle Biotechnology Price Performance
The stock has a market capitalization of £5.91 million, a PE ratio of -2,093.22 and a beta of 0.38. The business has a 50 day moving average price of GBX 1.74 and a 200 day moving average price of GBX 1.84.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Featured Articles
- Five stocks we like better than Cizzle Biotechnology
- What is a Low P/E Ratio and What Does it Tell Investors?
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- 5 Top Rated Dividend Stocks to Consider
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- How to Buy Gold Stock and Invest in Gold
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
